Updated on 1 October 2014
WuXi PharmaTech has appointed William Robert Keller as an independent director
Singapore: China bioscience service provider, WuXi PharmaTech, has appointed Mr William Robert Keller as an independent director on the Board of Directors to serve on strategy committee.
Mr Keller was the general manager of Roche China and Shanghai Roche Pharmaceutical from 1994 to 2003, and he served in various positions at Roche Group in South America and Asia from 1974 to 2003. He has been the vice chairman of the Shanghai Association of Enterprises with Foreign Investment, a senior consultant to the Shanghai Foreign Investment Development Board.
"I am delighted to join the board of WuXi PharmaTech, the leading China-based pharmaceutical R&D services company," said Mr Keller. "I look forward to working with my fellow directors to guide WuXi's continuing growth."
"We are very pleased to welcome Mr Keller to WuXi's board," said Dr Ge Li, chairman and CEO of WuXi PharmaTech. "His wealth of experience as an executive, director, and consultant in the pharmaceutical industry, both globally and in China, will be valuable as WuXi continues to build a comprehensive, integrated platform of services for our global life science customers."